ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.114,61
0,23%
S&P 500
5.473,23
0,00%
Dow Jones
38.778,10
0,00%
Euro vs US Dollar
1,07168
-0,22%
Bitcoin
65.090,86
-2,10%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Calithera Biosciences Inc (CALA)

  7. Calithera Biosciences Inc (CALA) News

CALA

Calithera Biosciences (CALA)

Calithera Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CALA
DatumZeitQuelleÜberschriftSymbolFirma
29/06/202322h01GlobeNewswire Inc.Calithera Biosciences Announces Update on Complete Liquidation and DissolutionNASDAQ:CALACalithera Biosciences Inc
15/06/202315h14Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CALACalithera Biosciences Inc
05/06/202323h17Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:CALACalithera Biosciences Inc
26/05/202322h29Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:CALACalithera Biosciences Inc
26/05/202313h09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CALACalithera Biosciences Inc
26/05/202313h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CALACalithera Biosciences Inc
22/05/202312h01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CALACalithera Biosciences Inc
19/05/202322h01GlobeNewswire Inc.Calithera Biosciences Announces Update on Complete Liquidation and DissolutionNASDAQ:CALACalithera Biosciences Inc
31/03/202312h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CALACalithera Biosciences Inc
14/03/202321h16Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CALACalithera Biosciences Inc
14/03/202321h13Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CALACalithera Biosciences Inc
14/03/202321h10Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CALACalithera Biosciences Inc
14/03/202321h09Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CALACalithera Biosciences Inc
14/03/202321h08Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CALACalithera Biosciences Inc
14/03/202321h07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CALACalithera Biosciences Inc
14/03/202321h05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CALACalithera Biosciences Inc
14/03/202321h03Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CALACalithera Biosciences Inc
03/03/202316h46Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CALACalithera Biosciences Inc
14/02/202317h49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CALACalithera Biosciences Inc
14/02/202314h04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CALACalithera Biosciences Inc
09/02/202322h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CALACalithera Biosciences Inc
08/02/202322h06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CALACalithera Biosciences Inc
25/01/202322h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CALACalithera Biosciences Inc
25/01/202322h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CALACalithera Biosciences Inc
25/01/202322h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CALACalithera Biosciences Inc
25/01/202322h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CALACalithera Biosciences Inc
25/01/202322h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CALACalithera Biosciences Inc
09/01/202314h08Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CALACalithera Biosciences Inc
09/01/202314h00GlobeNewswire Inc.Calithera Biosciences Announces Board Approval of Complete Liquidation and DissolutionNASDAQ:CALACalithera Biosciences Inc
08/12/202217h50Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CALACalithera Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CALA

Kürzlich von Ihnen besucht

TG
DTE
Deutsche Telekom
NASDAQ
AAPL
Apple
NASDAQ
GOOGL
Alphabet
TG
ALV
Allianz
TG
BAS
BASF
NYSE
DIS
Walt Disney
FX
EURUSD
Euro vs US Dollar
USOTC
ADDYY
Adidas (QX)
USOTC
BASFY
BASF (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
DBI
DAX
DAX
FX
EURJPY
Euro vs Yen
TG
LHA
Deutsche Lufthansa
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten